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Abstract 
Although it can be stated that the incidence of osteoradionecrosis of the jaws (ORNJ) in the last reported period 
decreases, the therapy of this diagnosis has a considerably more complicated continuance as with 
bisphosphonates osteonecrosis (BON). Oral findings are extensive, not only alveolar bones of jaws are affected 
by radiation, but also oral mucosa and salivary glands, resulting to a significant mucositis and xerostomia. 
Research in dental and oral surgery often involves materials and procedures which are capable of improving 
clinical outcomes in terms of percentages of success. The goal of this research was to find a treatment approach 
which could reduce bleeding, promote effective bone regeneration and rapid soft-tissue healing by employing 
resources which are easy to use at a modest cost. Patients in our study were divided into three categories: 
patients with newly diagnosed cancer waiting for treatment, patients after radiotherapy without signs of 
osteonecrosis and patients with fully developed osteoradionecrosis of jaws. 
Keywords: osteoradionecrosis; radiotherapy; antibiotics; oncological disease; wound healing; oral surgery; oral 
medicine 
1. Introduction  
Osteoradionecrosis of the jaws (ORNJ) is a serious secondary injury, characterized by bone tissue necrosis and 
failure to heal in 3–6 months [1]. ORNJ affects the mandible more often than the upper jaw (Fig. 3). It is caused 
by a different blood supply. Another factor is the dosage method of radiotherapy in head and neck area. Dosage 
higher than 60 greys is considered dangerous in many clinical reviews.  
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The largest amount of ORN is found after the radiation of tonsil carcinoma and retromolar region [2]. Curative 
surgery is often not possible due to the extent of tumour spread and the patient’s overall condition [3]. There are 
three theories of ORNJ formation. The first theory was developed in 1938. The reason of the ORNJ 
manifestation is the penetration of the infection from the oral cavity to the changed exposed bone after radiation. 
This theory explains highly probable formation after the tooth extraction, however does not explain spontaneous 
formation after radiation [4]. 
The next theory recognises that it primarily does not have to be an infection, but a group of following irradiation 
changes of the tissue and humeral metabolism. It uses expressions such as hypoxia, hypovascularity and 
hypocellularity in the radiated bone [5]. The last theory dealing with ORNJ stresses the immunological 
processes in the bone stimulated by its local radiation, that lead to fibrotic and atrophic changes with a  
subsequent bone resorption [6]. 
The development of necrosis will show swelling, pain in the affected area, usually in occlusion, intraoral 
exposed bone, possibly with ulceration, oro-cutal fistula formation either incomplete or complete. One of a 
problematic complication is trismus, it can occur progressively after radiation therapy and is most common 
when the elevator muscles are in the field of radiation [7].  The development of xerostomia, dysphagia, 
dysgeusia, and postradiation tooth decay reduces quality of life [8]. The necrotic tissue restricts healing and 
provides bacteria growing and thus allows the development of the infection. The bacteria limit in time the 
elevated levels of pro-inflammatory mediators and cytokines and the presents of leukocytes that purifies the 
wound from necrotic tissue and thereby to slow down the healing [9]. The incidence and severity of mucositis 
will vary from patient to patient. It will also vary from treatment to treatment. It is estimated that there is 40% 
incidence of mucositis in patients treated with standard chemotherapy and this will not only increase with the 
number of treatment cycles but also with previous episodes [10]. 
The side effects of radiation therapy of the oral cavity tissues are divided into acute (manifestation of the healing 
process) and chronic which occur after the end of the treatment. Tissues with rapid proliferation of the cell 
population (mucosa, cutaneous or glandular epithelium) respond by acute injury. Tissues with low proliferation 
(ligaments, bone tissue) respond with chronic changes. In chronic wounds there is a significant lack of vitamins 
and trace elements because of reduced food intake, malabsorption and hypersecretion [11]. 
Generally patient in good overall condition, with a small number of metastases and with longer predicted 
survival time of a standard fractionation radiation is applied five times a week 2.0 Gy (total 6 – 40 Gy). 
Conversely for patients with a worse condition, with multiple metastatic cancer and lower estimated survival 
time, accelerated irradiation is chosen. (e.g.12x2.5 Gy, 10x3.0 Gy, 5x4.0 Gy) or only single dose (1x8.0 Gy). 
From the view of the expected better tolerability an accelerated mode radiation can be performed by 
hypofractiation (1 – 3 times per week).For tumours of the oral cavity size T1 – T3 is recommended treatment 
with primary brachytherapy, which should be higher than 62.5 Gy and higher than 0.5 Gy/h, respectively [12]. 
Brachytherapy avoids xerostomia, extensive mucositis affecting the whole oral cavity, trismus, and also permits 
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future radiation therapy of possible secondary tumours in the head and neck area owing to the excellent 
protection of surrounding healthy tissues [13]. 
2. Materials and methods 
The methodology of the treatment was derived from the overall patient’s status, extensity of the necrotized area 
and level of discomfort in the oral cavity and oral hygiene. Every patient was covered intravenously with 
antibiotics in combination of amoxiciline with clavulanic acid and metronidazole. In analgesic therapy we 
mostly used pyrazolone derivatives such as metamizol, opioids pentazocine, and adjuvant care secured by 
myorelaxans, anticonvulsants, antiemetic and local anaesthetic. In our file 63 patients had been examined in the 
period 2013-2015. ORNJ affected patients more frequently in the mandible than in the maxilla, in the ratio of 
24:1. The reason is the difference blood supply of these anatomical regions and the dosage of radiotherapy. 
Dosages higher than 60 Gy were considered risky. The greatest amount of ORNJ occurred after irradiation of 
tonsil carcinoma and retromolar region. We consider the penetration of infection from the oral cavity into the 
bone after radiation as the underlying pathophyziological aspect of ORNJ. Disturbance of oral mucosa leads to 
irradiation changes of tissues and humoral metabolism. The immunology processes of local irritation in head 
and neck area led to tissue fibrosis, atrophy and subsequent resorption of alveolar bone. 
2.1 Patients with newly diagnosed cancer (waiting for radiotherapy) 
Patients with newly diagnosed cancer of head and neck were examined in the maxillofacial clinic before the 
beginning of the radiation therapy. The overall status of the oral cavity, oral hygiene standard of the patient, 
tooth allocation indicated for restoration with temporal fillings and teeth for extractions were evaluated. In this 
stage the fabrication of any prosthetic denture and dental implants were contraindicated, due to periostal lesions 
and mucosal decubits that could easily occur after radiation in oral cavity. We mainly focused on the sanitation 
of the caries lesions, extractions, dental hygiene and detection of oral abnormalities that caused complications in 
the oncological therapy. 
2.2 Patients after radiotherapy without signs of osteoradionecrosis development 
Occasionally, pain in the jaw bone or tooth loosening may be the only symptom with no evidence of other 
clinical or radiological abnormalities [14]. Patients who underwent radiation of the head and neck and no ORNJ 
was developed were instructed of the seriousness of this diagnosis, treated only conservatively and regularly 
observed. It is very important to follow strict oral hygiene habits including rinses with chlorehexydine 0.12 and 
eliminate smoking and alcohol. 
2.3 Patients with fully developed osteoradionecrosis of the jaws 
Patients with fully developed ORNJ underwent procedures during the antibiotics cover, if their status allowed it. 
In case of smaller local oral findings, necrectomy and mucoperiostal flap closure were performed. If local 
defects were wider, the surgical treatment was restricted to considerate necrectomy and sequestrectomy. 
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Removal of only symptomatic bony sequester with minimal disturbance of overlying soft tissue, might be 
appropriate [15]. In special cases (e.g. pathological fracture of mandible) the mandibulectomy was indicated. 
The next treatment possibility is the hyperbaric oxygen therapy (Figure 1, 2) its benefit is however denied by 
many authors and maybe contraindicated in tumour recurrence, poor general condition of the patient or with 
difficult cooperation. Previously, hyperbaric oxygen (HBO) was an important adjuvant to surgery in ORNJ. The 
rationale for using HBO is that the intermittent elevation of tissue oxygen tension stimulates collagen synthesis 
and fibroblastic proliferation, promotes the growth of new capillaries, and enhances the phagocyte ability of 
leukocytes [16]. On the other hand there are many other results suggesting the suitability of this treatment, in 
addition to surgical interventions [17]. From the prosthetic point of view the acrylic splint on alginate dental 
impression have been proven. The splint protected sharp bone edges from dynamic processes in the oral cavity 
environment. Protective stent presents an appropriate support and stability, which is necessary to generate a 
record of the appropriate denture base surface area, flange contour, and mucosal surface and to generate a record 
of the lining mucosa by making an impression [18]. Therefore, the objectives of making a complete denture 
impression are as follows: to generate a record of all anatomical landmarks in the oral cavity; to obtain strong 
adhesion or retention with the mucosal surface; and to obtain an appropriate border shape to maintain the 
adhesion [19]. Osteoradionecrosis of the jaws forms a difficult locality to make sufficient qualitative 
impressions it is sometimes difficult to generate an impression that adheres strongly to the damaged bone 
surface or the appropriate border shape [20]. Platelet rich plasma (PRP) therapy has been proposed as a 
complement to conservative surgery in order to enhance bone healing. The rationale for the employment of PRP 
in patients affected by ORNJ is based on the thesis that the presence of growth factors constitutes a substitute 
stimulation to bone healing, which is similar to physiological healing. The growth factors in PRP might 
accelerate epithelial wound healing, decrease tissue inflammation after surgery, improve the regeneration of 
bone and soft tissues, and promote tissue vascularization. The additional advantages related to the use of this 
product are its biocompatibility and safety, as an autologous product. 
 
 
                    Figure 1: ORN of the mandible                        Figure 2: Result of the HBO therapy after 2 y. 
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                Figure 3: Extensive ORN of the mandible                        Figure 4: Protective acrylic stent  
3. Results 
Of the group of 63 patients in the period 2013-2015 with confirmed ORNJ, 25 patients had a pathological 
mandible fracture. In 14 patients we managed to stabilize this complication. In 6 cases with osteosynthetic 
material (Figure 5, 6). In 8 cases we covered an extensive ORNJ with acrylic splint (Figure 4) since it was not 
possible to perform osteosynthesis due to unsatisfactory anatomical conditions. This splint not only stabilized 
the pathological fractures, but also protected oral mucosa against sharp bone edges of the alveolar bone. The 
remaining 11 patients underwent necrectomy of fractured bulges of mandible in general anaesthesia. In 18 
patients we managed to stabilize the process of ORNJ by local treatment, necrectomy, egalization of sharp edges 
and intravenously administered antibiotics. 20 patients underwent PRP therapy with a positive outcome in 
follow-up period with fast mucosal healing, a reduced need for analgesics and a resolution of mouth lesions 
(Figure 7, 8, 9, 10, 11, 12). This improved the quality of life, food intake and speech. In this last group patients 
had only smaller lesions, which did not present a risk of pathological fracture and other complications. An 
important factor was the patient motivations to improve oral cavity hygiene and our regular recall. Patients 
received regular follow-ups including MRI scans, X rays and clinical exams 6–8 weeks post completion of 
radiotherapy, 3, 6, and 12 months thereafter. As mentioned above, the most common (36 cases) carcinoma in 
retro molar region and tonsils ORNJ occurred due to the relatively difficult access in relation to radiotherapy. 
The second most common area affected by tumour region was the base of the mouth (13 cases). Another group 
was patients with tongue carcinoma (10 cases). In the last group we had 4 patients with carcinoma of bucal 
mucosa. 
4. Discussion 
In terms of the oral cavity treatment it is very difficult and long lasting leaves the patient with painful exposed 
bone lesions in the oral cavity, which complicates his food intake and care of the oral cavity. The therapy is 
necessary as soon as possible and any period without therapeutical steps prolongs the treatment and worsens the 
overall diagnosis. Shawn and his colleagues [21] described primary prevention of ORNJ in 1999 as the most 
important stage in the systematic treatment of this serious and unwanted illness complication. In 2003, Sulaiman 
[22] published the importance of oral dental hygiene and the comprehensive dental examination prior to 
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initiation of radiotherapy and especially after its completion for compliance with the preventive programs and 
enhanced empirical experience. For these reasons there are now professional public accessible registers of 
osteoradionecrosis which are designed to record the newly established diagnosis and subsequent treatment. 
Developing ORNJ is variable and its etiopathogenesis is not until today thoroughly understood. Clinical studies 
aim to define the role and express the value of etiopathogenetic moments at the molecular and cellular 
level.Burke and his colleagues [23] recommends supporting the treatment by Pentoxifylline and vitamin E as an 
ideal antioxidant treatment at doses of 800mg Pentoxifylline and 1000 IU vitamin E for a minimum period of 6 
month thereby supporting faster healing post radiation mucositis and soft tissue regeneration. Despite the 
potential risk of surgical treatment failure (immunocompromised patients, diabetes mellitus, pathological 
fracture etc.) the closure of sharp bone edges alveolar process appears to be the best solution. 
 
       Figure 5: Pathological fracture of the mandible                 Figure 6: Osteosynthesis of the fracture 
This type of treatment, however, must be preceded by strict hygiene training, patient motivation, and local 
debridement of necrotic bone parts. The issue of antibiotic prophylaxis is significant to help prevent infection 
after surgical intervention, but also the conventional extraction in the preventive face of treatment. British 
Association of Oral and Maxillofacial Surgeons recommend using and applying antibiotic prophylaxis in the pre 
surgical preparation but also in the post operative period. Despite these results, it can be stated that no global 
consensus on the choice, timing and length antibiotic treatment was declared [24]. ORNJ of oncological patients 
do not develop immediately, but after a certain time. After radiotherapy the possibility of necrosis is partly 
expected and the patient is informed. When recurrence of cancer after prior radiation poses a high risk to ORNJ 
without the possibility of surgical salvage patients face the choice between palliative chemotherapy and re-
irradiation [25]. It is very encouraging that the number of ORNJ is declining due to the application of preventive 
measures before and during treatment with ionizing radiation [26]. 
5. Conclusion 
The osteoradionecrosis treatment is difficult and long-lasting and leaves the patient with an exposed bone lesion 
which complicates food intake and oral hygiene care. Surrounding soft tissues lose their natural elasticity and 
are subject to post-radiation changes and tissue fibrosis. This negatively influences the treatment and aftercare 
of the oncological disease. 
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Figure 7: ORN of the upper jaw                              Figure 8: Extensive surgery necrectomy 
 
 
                Figure 9: Platelet-Rich Plasma concentrates                          Figure 10: Application of the PRP 
 
 
                     Figure 11: Closure of defect                                             Figure 12: Status after 3 month 
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Extensive debridement and local flap closure seem to be unsuccessful because of hypovascularity of soft and 
hard tissues. In serious cases radical resection of necrotic bone and immediate free flap reconstruction is 
considered as the best or only solution. General health or local reasons do not always allow this type of 
reconstruction. Usually conservative approach with minimal surgical intervention and antibiotics cover is 
recommended. In spite of this, no effective therapy for osteoradionecrosis has been established, an empirical 
conservative therapy is recommended in the guidelines. Key to success is prevention or treatment in initial 
phase. It depends on cooperation between the oncologist, dentist, maxillofacial surgeon and setting a diagnosis 
in the shortest possible time. The combination of necrotic bone curettage and PRP application seem to be 
encouraging for the treatment of BRONJ, as it has demonstrated successful outcomes with minimal invasivity. 
6. Recommendations 
This article confirms the need to approach the patients multi - disciplinarily and very carefully with multimodal 
treatment including patient knowledge’s about importance of the oral hygiene and also, the development of this 
disease process is important to establish treatment strategies that are evidenced based and associated with valid 
outcome data. 
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